All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF756 | Anti-Human PSA (XW-756) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-756 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF757 | Anti-Human PSA (XW-757) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-757 | Human | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1676 | Anti-Human PSA (XW-756) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-756 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1677 | Anti-Human PSA (XW-757) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-757 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2596 | Anti-Human PSA (XW-756) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-756 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2597 | Anti-Human PSA (XW-757) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-757 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8648 | TS-Fluc Anti-Human PSA scFv (XW-756) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-756 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8649 | TS-Fluc Anti-Human PSA scFv (XW-757) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-757 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9057 | TS-Fluc Anti-Human PSA scFv (XW-756) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-756 | Mouse | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9058 | TS-Fluc Anti-Human PSA scFv (XW-757) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-757 | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9466 | TS-Fluc Anti-Human PSA scFv (XW-756) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-756 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9467 | TS-Fluc Anti-Human PSA scFv (XW-757) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-757 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9875 | TS-IL15 SA Anti-Human PSA scFv (XW-756) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-756 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9876 | TS-IL15 SA Anti-Human PSA scFv (XW-757) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-757 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF10284 | TS-IL15 SA Anti-Human PSA scFv (XW-756) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-756 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10285 | TS-IL15 SA Anti-Human PSA scFv (XW-757) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-757 | Human | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10693 | TS-IL15 SA Anti-Human PSA scFv (XW-756) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-756 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10694 | TS-IL15 SA Anti-Human PSA scFv (XW-757) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-757 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-1122-LX433 | Anti-PSA (X11X35) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | X11X35 | Mouse | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell | ||
XS-1122-LX434 | Anti-PSA (X11X36) h(CD28-OX40-CD3ζ) CAR, pCDCAR1 | Human | X11X36 | Humanized | scFv-CD28-OX40-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION